中信建投证券股份有限公司 关于北京天智航医疗科技股份有限公司 与关联人共同投资的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"或"保荐机构"） 作为北京天智航医疗科技股份有限公司（以下简称"天智航"或"公司"）2021 年度向特定对象发行 A 股股票的保荐机构，根据《证券发行上市保荐业务管理 办法》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司 自律监管指引第 1 号——规范运作》和《科创板上市公司持续监管办法（试行）》 等有关规定，对天智航与关联人共同投资事项进行了审慎核查，核查情况及核查 意见如下： 一、关联对外投资概述 （一）对外投资的基本概况 1、本次交易概况 为进一步加强产、学、研、医深度融合，创新合作机制，打通跨学科壁垒， 打造集前沿技术突破、学科人才培养、生产制造赋能、临床应用示范全流程一体 化的现代化医疗机器人产业学院典范，促进医疗机器人行业升级与效能提升，构 建新型创新应用生态环境。公司拟与安徽东南医学科技发展有限责任公司（以下 简称"东南医学"）、安徽启江智能科技有限公司（以下简称"启江智能"）、安徽 邦泰天玑智能医疗创新中心有限公司（以下简称"邦泰天玑" ...

证券代码：688277 证券简称：天智航 公告编号：2025-046 北京天智航医疗科技股份有限公司 与关联人共同投资公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 本次关联交易事项已经公司第六届董事会独立董事专门会议第七次会议、第 五届监事会第十二次会议、第六届董事会第二十五次会议审议通过，关联董 事已回避表决。未达到股东大会审议标准，无需提交股东大会审议。 其它需要提醒投资者重点关注的风险事项 本次交易的达成尚存在不确定性，敬请广大投资者谨慎投资，注意投资风险。 一、关联对外投资概述 （一）对外投资的基本概况 1、本次交易概况 为进一步加强产、学、研、医深度融合，创新合作机制，打通跨学科壁垒， 打造集前沿技术突破、学科人才培养、生产制造赋能、临床应用示范全流程一体 重要内容提示： 投资标的名称：东南医疗装备产业发展有限公司（暂定名，最终以工商 登记核准名称为准） 截至本次关联交易为止（含本次），北京天智航医疗科技股份有限公司 （以下简称"公司"或"天智航"）过去 12 个月内与同一关联人进行的非 日常关联交易累计次数 ...

一、监事会会议召开情况 北京天智航医疗科技股份有限公司（以下简称"公司"）第五届监事会第十 二次会议通知于 2025 年 11 月 21 日以电子邮件方式送达公司全体监事，于 2025 年 11 月 28 日以现场结合通讯方式召开，应出席监事 3 人，实际出席监事 3 人。 本次会议由监事会主席张维军先生主持。本次监事会会议的召开符合《公司法》 《公司章程》等有关规定，会议决议合法有效。 二、监事会会议审议情况 全体监事以投票方式通过如下决议： 1、审议通过《关于公司与关联人共同投资的议案》 证券代码：688277 证券简称：天智航 公告编号：2025-045 北京天智航医疗科技股份有限公司 第五届监事会第十二次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本次与关联人共同投资遵循了公平、合理的原则，不存在损害公司及其股东、 特别是中小股东利益的行为，本次关联交易的审议程序符合法律、法规及《公司 章程》等有关规定。 具体内容详见公司同日刊登在上海证券交易所网站（www.sse.com.cn）的《与 关联人共 ...

Core Viewpoint - The company plans to invest in a joint venture to establish a new medical equipment development company with a total investment of 10 million yuan, where the company will contribute 2 million yuan, representing a 20% stake [1] Group 1: Investment Details - The total investment for the new company, Southeast Medical Equipment Industry Development Co., Ltd., is set at 10 million yuan [1] - The company will contribute 2 million yuan in cash, accounting for 20% of the total investment [1] Group 2: Corporate Governance - The transaction has been approved by the company's sixth board of directors' independent directors' special meeting, the fifth supervisory board's twelfth meeting, and the sixth board of directors' twenty-fifth meeting [1] - Related directors have abstained from voting, and there is no need for shareholder meeting approval [1]

Group 1 - On November 28, Tianzhihang executed a block trade of 140,000 shares, with a total transaction value of 2.016 million yuan, accounting for 4.38% of the total trading volume for the day [1] - The transaction price was 14.4 yuan, which represents an 8.4% discount compared to the market closing price of 15.72 yuan [1][2] - The buying department for the transaction was identified as "Thought Teacher Teaching Performer," and the selling department was marked as "KO" [2]

Core Insights - Tianzhihang-U executed a total of 6 block trades on November 27, with a cumulative trading volume of 1.94 million shares and a total transaction value of 27.936 million yuan, at a price of 14.40 yuan, representing an 8.28% discount compared to the closing price of the day [2] Trading Activity - The block trades included 2 transactions involving institutional proprietary seats, with a total transaction value of 19.872 million yuan and a net purchase of 19.872 million yuan [2] - Over the past three months, the stock has recorded 8 block trades with a total transaction value of 31.968 million yuan [2] Stock Performance - On the same day, Tianzhihang-U closed at 15.70 yuan, down 0.44%, with a turnover rate of 0.42% and a total trading volume of 30.128 million yuan, indicating a net outflow of 1.1399 million yuan in main funds [2] - In the last five days, the stock has declined by 5.02%, with a total net outflow of 17.4857 million yuan [2] Margin Financing - The latest margin financing balance for the stock is 221 million yuan, which has decreased by 17.3013 million yuan over the past five days, reflecting a decline of 7.26% [2]

Summary of Key Points Core Viewpoint - On November 27, Tianzhihang executed a block trade of 1.94 million shares, amounting to 27.936 million yuan, which accounted for 48.11% of the total trading volume for the day. The transaction price was 14.4 yuan, representing an 8.28% discount compared to the market closing price of 15.7 yuan [1]. Group 1: Trading Details - The block trade involved a total of 1.94 million shares at a price of 14.4 yuan per share [1]. - The total transaction value was 27.936 million yuan, indicating significant trading activity [1]. - The discount of 8.28% from the market closing price suggests a strategic pricing decision in the context of market conditions [1]. Group 2: Institutional Participation - Multiple institutional buyers participated in the trades, indicating strong interest from professional investors [2]. - The trades were executed through specialized institutional channels, reflecting a targeted approach to acquiring shares [2]. - The involvement of institutional investors may signal confidence in the company's future performance despite the discount [2].

Summary of Key Points Core Viewpoint - Tianzhihang-U experienced significant trading activity on November 26, with a total transaction volume of 280,000 shares and a transaction value of 4.032 million yuan, indicating a discount of 8.69% compared to the closing price of the day [1]. Trading Activity - The stock closed at 15.77 yuan, down 0.76%, with a turnover rate of 0.48% and a total transaction amount of 35.0772 million yuan for the day [1]. - There was a net outflow of 1.4695 million yuan in main capital throughout the day, and the stock has seen a cumulative decline of 5.34% over the past five days, with a total net outflow of 19.451 million yuan [1]. Margin Financing Data - The latest margin financing balance for the stock is 222 million yuan, which has decreased by 17.795 million yuan over the past five days, representing a decline of 7.43% [1].

Group 1 - The core transaction involved Tianzhihang, with a total of 280,000 shares traded on November 26, amounting to 4.032 million yuan, which represents 10.31% of the total trading volume for that day [1] - The transaction price was 14.4 yuan per share, reflecting an 8.69% discount compared to the market closing price of 15.77 yuan [1]

Core Viewpoint - Tianzhihang's stock price has experienced a decline recently, despite a significant increase in its stock price year-to-date, indicating potential volatility in the market [1][2]. Company Overview - Tianzhihang Medical Technology Co., Ltd. specializes in the research, production, sales, and service of orthopedic surgical navigation robots, with a revenue composition of 58.31% from navigation robots, 23.86% from supporting equipment and consumables, 16.49% from technical services, and 1.31% from other sources [1]. - The company was established on October 22, 2010, and went public on July 7, 2020 [1]. Financial Performance - For the period from January to September 2025, Tianzhihang reported a revenue of 187 million yuan, representing a year-on-year growth of 103.51%. However, the net profit attributable to shareholders was -114 million yuan, a decrease of 49.73% compared to the previous year [2]. - The stock price has increased by 55.26% year-to-date, but has seen declines of 8.76% over the last five trading days, 12.22% over the last twenty days, and 22.18% over the last sixty days [1]. Shareholder and Market Activity - As of September 30, 2025, the number of shareholders increased by 12.31% to 17,300, with an average of 26,094 shares held per shareholder, a decrease of 10.96% [2]. - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent appearance on February 17, where it recorded a net purchase of 26.27 million yuan [1]. Market Position - Tianzhihang is categorized under the pharmaceutical and biological industry, specifically in medical devices, and is associated with concepts such as robotics, specialized innovation, and medical equipment [2].